CB1 cannabinoid receptor antagonists for treatment of obesity and prevention of comorbid metabolic disorders.
J Med Chem. 2006 Jul 13;49(14):4008-16. doi: 10.1021/jm058238r.
J Med Chem. 2006.
PMID: 16821760
Review.
No abstract available.